DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)

Clinical safety rating: avoid

Other cardiotoxic drugs (eg trastuzumab) increase risk Can cause severe and irreversible cardiotoxicity and myelosuppression.

How it works

Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.

Solution 2 mg/mL - Intravenous

Dosage form	INJECTABLE, LIPOSOMAL
Renal impairment	Consult protocols for adjustment.
Liver impairment	Consult protocols for adjustment.

Clinical note

Other cardiotoxic drugs (eg trastuzumab) increase risk Can cause severe and irreversible cardiotoxicity and myelosuppression.

FDA category

Category Contraindicated

cardiotoxicity

Loading safety data…

Clinical safety rating: avoid

Other cardiotoxic drugs (eg trastuzumab) increase risk Can cause severe and irreversible cardiotoxicity and myelosuppression.

Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.

Solution 2 mg/mL - Intravenous

Dosage form	INJECTABLE, LIPOSOMAL
Renal impairment	Consult protocols for adjustment.
Liver impairment	Consult protocols for adjustment.

Clinical note

Other cardiotoxic drugs (eg trastuzumab) increase risk Can cause severe and irreversible cardiotoxicity and myelosuppression.

FDA category

Category Contraindicated

cardiotoxicity

Loading safety data…